Ionis Pharmaceuticals Inc (IONS): Cash & Equivalents
$372.26M
As of 2025-12-31
$350.06M
As of 2026-06-30
+10.4%
3-year compound annual growth
-1.3%
5-year compound annual growth
+11.2%
10-year compound annual growth
| Period ended | Cash & Equivalents | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $372.26M | +53.8% | 2026-02-26, Balance as of period end |
| 2024-12-31 | $242.08M | -39.4% | 2026-02-26, Balance as of period end |
| 2023-12-31 | $399.27M | +44.4% | 2025-02-19, Balance as of period end |
| 2022-12-31 | $276.47M | -68.2% | 2024-02-21, Balance as of period end |
| 2021-12-31 | $869.19M | +118.6% | 2023-02-22, Balance as of period end |
| 2020-12-31 | $397.66M | -41.8% | 2022-02-25, Balance as of period end |
| 2019-12-31 | $683.29M | +145.1% | 2021-02-24, Balance as of period end |
| 2018-12-31 | $278.82M | +115.1% | 2020-03-02, Balance as of period end |
| 2017-12-31 | $129.63M | +53.1% | 2019-03-01, Balance as of period end |
| 2016-12-31 | $84.69M | -34.2% | 2019-03-01, Balance as of period end |
| 2015-12-31 | $128.80M | -9.9% | 2018-02-28, Balance as of period end |
| 2014-12-31 | $143.00M | -10.6% | 2017-03-01, Balance as of period end |
| 2013-12-31 | $159.97M | +28.5% | 2016-02-26, Balance as of period end |
| 2012-12-31 | $124.48M | +90.1% | 2015-03-02, Balance as of period end |
| 2011-12-31 | $65.48M | -6.5% | 2014-03-03, Balance as of period end |
| 2010-12-31 | $70.05M | -33.4% | 2013-02-28, Balance as of period end |
| 2009-12-31 | $105.25M | -53.0% | 2012-02-29, Balance as of period end |
| 2008-12-31 | $223.99M | n/a | 2011-03-01, Balance as of period end |
Cash & Equivalents at similar companies
| Company | Year ended | Cash & Equivalents | Change YoY |
|---|---|---|---|
| Ionis Pharmaceuticals Inc (IONS) | 2025-12-31 | $372.26M | +53.8% |
| Madrigal Pharmaceuticals, Inc. (MDGL) | 2025-12-31 | $198.69M | +98.7% |
| ANI Pharmaceuticals Inc (ANIP) | 2025-12-31 | $285.58M | +97.1% |
| Harmony Biosciences Holdings, Inc. (HRMY) | 2025-12-31 | $752.50M | +66.1% |
| Acadia Pharmaceuticals Inc (ACAD) | 2025-12-31 | $177.69M | -44.4% |
| Prestige Consumer Healthcare Inc. (PBH) | 2026-03-31 | $63.87M | -34.8% |
| Collegium Pharmaceutical, Inc (COLL) | 2025-12-31 | $231.25M | +227.7% |
| Corcept Therapeutics Inc (CORT) | 2025-12-31 | $120.50M | -5.6% |
| Emergent BioSolutions Inc. (EBS) | 2025-12-31 | $205.40M | +106.4% |
Compare IONS, MDGL, ANIP, HRMY side by side · Screen every company in Pharmaceutical Preparations ↗